These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9092417)

  • 1. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy in peripheral arterial occlusive disease.
    Clagett GP; Graor RA; Salzman EW
    Chest; 1992 Oct; 102(4 Suppl):516S-528S. PubMed ID: 1395832
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet therapy in peripheral occlusive arterial disease.
    Wong S; Appleberg M; Lewis DR
    ANZ J Surg; 2006 May; 76(5):364-72. PubMed ID: 16768698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulant therapy in patients with peripheral artery disease.
    Visseren FL; Eikelboom BC
    Semin Vasc Med; 2003 Aug; 3(3):339-44. PubMed ID: 15199468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Dörffler-Melly J; Schmidli J; Mahler F
    Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet and anticoagulant therapy to prevent bypass graft thrombosis in patients with lower extremity arterial occlusive disease.
    Adam DJ; Stonebridge PA; Belch JJ; Murie JA
    Int Angiol; 2001 Mar; 20(1):90-8. PubMed ID: 11343000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 1998 Nov; 114(5 Suppl):666S-682S. PubMed ID: 9822070
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in peripheral arterial disease.
    Lipsitz EC; Kim S
    Clin Geriatr Med; 2006 Feb; 22(1):183-98, x. PubMed ID: 16377474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Milani RV
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in peripheral arterial occlusive disease.
    Clagett GP; Krupski WC
    Chest; 1995 Oct; 108(4 Suppl):431S-443S. PubMed ID: 7555194
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimum perioperative drug therapy following lower-extremity vein bypass surgery?
    Henke P
    Semin Vasc Surg; 2009 Dec; 22(4):245-51. PubMed ID: 20006805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of peripheral arterial diseases].
    Mikita J
    Orv Hetil; 2005 May; 146(22):1209-11. PubMed ID: 15997667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.